Inventors:
Evan D. Rosen - Arlington MA, US
International Classification:
A61K 31/07, C12Q 1/02, C12Q 1/68, G01N 33/53, A61K 39/395, C07C 43/02, C07K 16/00, A61P 3/10
US Classification:
4241721, 435 29, 435 6, 514725, 435 78, 568668, 5303898
Abstract:
Methods of identifying compounds that modulate lipocalin 2 activity or expression are described, as are methods of reducing insulin resistance or increasing insulin sensitivity by administering compounds that modulate lipocalin 2 expression. Methods of diagnosing insulin resistance or related conditions, by measuring lipocalin 2 activity, are also described.